QuidelOrtho (QDEL) Change in Receivables (2021 - 2026)
QuidelOrtho's (QDEL) quarterly Change in Receivables came in at -$54.0 million in Q1 2026, down 2354.55% year-on-year from $2.4 million in Q1 2025, and down 287.5% quarter-over-quarter from $28.8 million in Q4 2025.
QuidelOrtho (QDEL) Change in Receivables (2021 - 2026) Analysis & Trends
QuidelOrtho has disclosed Change in Receivables across 6 years of filings, most recently posting -$54.0 million for Q1 2026.
- Change in Receivables for Q1 2026 came in at -$54.0 million, down 2354.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.7 million (up 249.47% YoY), and the FY2025 annual result was $117.5 million, up 2275.93% from the prior year.
- Change in Receivables came in at -$54.0 million for Q1 2026 at QuidelOrtho, down from $28.8 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $191.5 million in Q2 2022 to a low of -$187.2 million in Q2 2023.
- The 5-year median for Change in Receivables is $2.2 million (2024), against an average of $6.7 million.
- Across the five-year window, Change in Receivables surged 1209.09% in 2025 and tumbled 2354.55% in 2026, its largest moves.
- QuidelOrtho's Change in Receivables stood at $191.5 million in 2022, then slumped by 118.75% to -$35.9 million in 2023, then jumped by 106.13% to $2.2 million in 2024, then surged by 1209.09% to $28.8 million in 2025, then tumbled by 287.5% to -$54.0 million in 2026.
- The last three Change in Receivables figures came in at -$54.0 million (Q1 2026), $28.8 million (Q4 2025), and $113.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | QuidelOrtho | 934.34 Mn | 793.94 Mn | - | -54.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -54.00 Mn |
| Mar 29, 2026 | -54.00 Mn |
| Dec 28, 2025 | 28.80 Mn |
| Dec 28, 2025 | 28.80 Mn |
| Sep 28, 2025 | 113.40 Mn |
| Sep 28, 2025 | 113.40 Mn |
| Jun 29, 2025 | -22.50 Mn |
| Jun 29, 2025 | -22.50 Mn |
| Mar 30, 2025 | -2.20 Mn |
| Mar 30, 2025 | -2.20 Mn |
| Dec 29, 2024 | 2.20 Mn |
| Dec 29, 2024 | 2.20 Mn |
| Sep 29, 2024 | 16.60 Mn |
| Sep 29, 2024 | 16.60 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | -26.40 Mn |
| Mar 31, 2024 | -26.40 Mn |
| Dec 31, 2023 | -35.90 Mn |
| Dec 31, 2023 | -35.90 Mn |